In fact, Kato et al. observed significantly higher P-gp protein levels in EVs from a cohort of docetaxel-resistant prostate cancer patients compared to EVs from patients not exposed to chemotherapy [178]. The gene discussed is PGP; the disease is prostate carcinoma.